Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-019321
Filing Date
2025-07-03
Accepted
2025-07-03 16:21:24
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 form4-07032025_080720.html 4  
1 form4-07032025_080720.xml 4 7579
  Complete submission text file 0001415889-25-019321.txt   9126
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Issuer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address
Karas Eric (Reporting) CIK: 0001951287 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 251105819